H1B Report
Side-by-side comparison

INFOSYS LIMITED vs Southern Illinois University School of Medicine

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
INFOSYS LIMITED
TXRank #1FEIN 58-1760235

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricINFOSYS LIMITEDSouthern Illinois University School of Medicine
Total filings205,263310
Certified %99.55%80.65%
Denied %0.21%4.84%
Withdrawn %0.20%2.26%
Cert-withdrawn %0.05%12.26%
Rank#1
Active yearsFY2010–FY2026FY2010–FY2026
Worksite stateTXIL

Outcomes — INFOSYS LIMITED

DOL case-status mix.

Outcome breakdown: Certified 99.5%, Cert-withdrawn 0.0%, Withdrawn 0.2%, Denied 0.2%
Outcome breakdown
OutcomeShare
Certified99.5%
Cert-withdrawn0.0%
Withdrawn0.2%
Denied0.2%
Certified99.5%
Cert-withdrawn0.0%
Withdrawn0.2%
Denied0.2%

Outcomes — Southern Illinois University School of Medicine

DOL case-status mix.

Outcome breakdown: Certified 80.6%, Cert-withdrawn 12.3%, Withdrawn 2.3%, Denied 4.8%
Outcome breakdown
OutcomeShare
Certified80.6%
Cert-withdrawn12.3%
Withdrawn2.3%
Denied4.8%
Certified80.6%
Cert-withdrawn12.3%
Withdrawn2.3%
Denied4.8%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

INFOSYS LIMITED
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20102,164
FY20111,681
FY201214,701
FY201332,232
FY201423,749
FY201533,214
FY201625,335
FY201720,571
FY201811,569
FY201921,420
FY202016
FY202129
FY202222
FY20232,269
FY20245,943
FY20255,790
FY20264,558
Southern Illinois University School of Medicine
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY201019
FY201118
FY201217
FY201312
FY201425
FY201518
FY201626
FY201728
FY201823
FY201925
FY20200
FY20215
FY20220
FY20232
FY202431
FY202544
FY202617

Top 5 occupations — INFOSYS LIMITED

Top 5 occupations — Southern Illinois University School of Medicine

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.